FDA Investigator Jorge L Gonzalez

Jorge L Gonzalez has inspections in 7 countries as of 07 Sep 2023. Jorge L Gonzalez has collaborated with a combinined 1659 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
21
Last Inspection Date:
07 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Switzerland, Germany, Israel, Turkey, Czechia, Spain
Co-Investigator(s):
Agnes M Santori, Alan P Kurtzberg, Alberto A Viciedo, Ana M Rivera, Ariel Cruz Figueroa, Arlene M Badillo, Brenda Rivera, Brooke K Higgins, Candido Torres, Carlos A Medina, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Cynthia J Lee, MS, Dayna I Martinez, Devaughn Edwards, Dr. Carmelo Rosa, Dr. Robert C Horan, MD, Edecia A Richards, Eric L Dong, BS, Erika E Englund, PhD, Erika V Butler, Felix Maldonado, German Rivera, Gwyn G Dickinson, Hector J Colon Torres, Isabel Y Espinosa, Ivis L Negron, Ivis Lnegron Torres, Jaime E Pares, James C Maclaughlin, James I Giefer, John D White, Jorge L Guadalupe, Jorge L Lajara, Jose A Moreno, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose F Pedro, Jose F Pedró, Jose Fpedrode Jesus, Jose Melendez, Jose Velez, Juan Rjimenez Garcia, Justin A Boyd, Karl D Hezel, Kevin D Kallander, Laiza V Garcia, Latorie S Jones, Laurimer Kuilan Torres, Liatte Kreuger, PharmD, Libia M Lugo, Lucas B Leake, Luis A Carrion, Margaret M Annes, Maria A Ruttell, Maribel V Juarbe, Matthew B Casale, Medina, Meisha R Sampson, Meisha Waters, Michael A Charles, Michael A Taylor, Michael R Goga, Michelle D Haamid, Miguel A Martinez, Myriam M Sosa, Neisa M Alonso, Noreen Muniz, Patrick C Klotzbuecher, Paul A Bonneau, Paul L Bellamy, Rafael Nevarez Nieves, Ramon A Hernandez, Raquel Gonzalez Rivera, Rebeca M Melendez, Rebecca Parrilla, Rebecca Rodriguez, Robert C Horu, PhD, Rochelle K Kimmel, Roger F Zabinski, Santos E Camara, Satheesh Thomas, Shelby N Marler, Sixto M Mercado Rios, Steven B Barber, Susan W Ting, Torrance J Slayton, Walden H Lee, Wayne D Mcgrath, Yeissa Chabrier Rosello, Yvesna C Blaise

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more